Ilika plc Toyota brings AI into accelerated materials discovery with Ilika

Ilika plc
[shareaholic app="share_buttons" id_name="post_below_content"]

On March 9th Ilika plc (LON:IKA) announced a $1m deal with its established blue chip partner Toyota Motor Corp (TYO:7203) in ‘a new application area’. Yesterday’s RNS reveals, via an announcement from the Toyota Research Institute (‘TRI’), that the new area is the application of artificial intelligence (‘AI’) to rapid materials discovery. TRI is investing $35m over four years with Ilika, and a handful of world-class R&D institutions, which includes Stanford and MIT, to incorporate AI into materials discovery. The goal of the program is to significantly accelerate the process further, and increase the number of materials made, thus increasing the number of new improved materials discovered. As the world’s largest automotive company, Toyota’s key initial target areas are advanced materials for battery and fuel-cell catalysts, which improve performance and reduce emissions. Toyota targets reducing its new vehicle emissions by 90% by 2050. TRI was established in 2015 and is wholly owned by Toyota North America. Ilika is the only project partner cited outside the USA.

* A blue chip endorsement of Ilika’s world-class materials R&D status. For Ilika to be selected by the Toyota Research Institute as the only non-US project partner alongside world-class institutions of the caliber of Stanford and MIT, is testament to the high quality of Ilika’s materials discovery and R&D capabilities. It also gives positive insight into the depth of Ilika’s on-going relationship with Toyota.

Share on:
Find more news, interviews, share price & company profile here for:

Ilika moves into commercial phase with first Stereax electrode order

Ilika has received its first commercial order for Stereax battery electrodes, marking the start of scaled production for medical device applications.

Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video)

Ilika plc has crossed a commercial milestone with its first regular revenue stream from its Stereax battery line, according to Dr Tom McColm of Morphose Capital. With strong cash reserves, momentum on its Goliath platform, and growing interest from defence sectors, the next 12 months could be transformational.

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

Ilika CEO Graeme Purdy shares how the company has shifted from commissioning to customer deliveries of its Stereax batteries — and why its Goliath EV programme is designed to beat the commoditised market with faster charging and extended range.

Ilika reports on-track progress across Stereax and Goliath in H1 2025/26

Ilika reports unaudited half-year results to 31 October 2025, highlighting on-schedule delivery of key commercial milestones across its Stereax medical battery and Goliath EV battery programmes, alongside continued customer validation, pilot-line commissioning, and £4.2m fundraising to support its roadmap.

Ilika secures first commercial Stereax electrode order from Cirtec Medical

Ilika has received its first revenue-generating purchase order from Cirtec Medical for the supply of Stereax electrodes, marking the transition of their partnership into commercial production.

Solid state design drives weight, cost and efficiency gains

Solid state design offers Ilika a compelling path to value through weight savings, pack simplification and improved EV performance.

Search

Search